Reports and Data

Precision Oncology Market Size, Business Opportunities, Development, CAGR of 9.9%, Expansion, Merger, Acquisition, and Pricing Analysis by 2027

Market Size – USD 49.98 Billion in 2019, Market Growth - CAGR of 9.9%, Market Trends – Improvement and advancement in cancer biology.

 

New York, NY -- (SBWIRE) -- 04/19/2021 -- The advancement in healthcare is beneficial for patients, the pharmaceutical industry, and society.

Market Size – USD 49.98 Billion in 2019, Market Growth - CAGR of 9.9%, Market Trends – Improvement and advancement in cancer biology.

The global Precision Oncology market is forecast to reach USD 99.72 Billion by 2027, according to a new report by Reports and Data. Precision oncology categories, recent advances in cancer care have been closely associated with genomic medicine. Knowing the genetic mutations of unique tumors holds the promise of giving practitioners a higher capacity to command specific prescriptions to fight specific tumors types. Although, only a few tumors and tumor types have been correlated with specific genetic mutations. In some forms of breast cancer, doctors instantly have years of expertise in genomic analysis to determine the most appropriate methods for their patients.

Physicians immediately can use DNA testing to look for the mutation of the gene; meanwhile, women with a family story of breast or ovarian cancer. Additionally, the combination of big data healthcare organizations with pharma & biotech corporations is likely to support market growth. On the other hand, the lack of awareness about the possible applications of precision medication and the compensation policies and regulatory framework is expected to hamper the market extension.

Key participants include Companies considered and profiled in this market study, Eagle Genomics, ASEBIO, Menarini Silicon Biosystems, NanoString Technologies, Inc. NeoGenomics, Novartis AG, Pfizer Inc., QIAGEN, Tepnel Pharma Services, Teva Pharmaceuticals Industries Ltd, among others.

The COVID-19 impact:
With the increase in the COVID-19 crisis, manufacturers are rapidly changing their practice & purchasing priorities to meet the demand of the pandemic. However, with an increase in investment in healthcare, the market will experience a rise in demand. The forecast of the market will offer in-depth insight into industry parameters by different factors of the market trends, and several price fluctuations.

Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/3353

Further key findings from the report suggest

- The global Precision Oncology market accounted for USD 49.98 billion in 2019 and is expected to grow at a CAGR of 9.9% from 2019 to 2027.
- The Application is anticipated to reach USD 22.33 billion by 2027 and is expected to grow at a high rate over the forecast period.
- The End-user segment dominated the market in 2019, with an estimated USD 99.72 billion.
- The Biotechnology companies are the largest segment and are estimated to generate revenue of over USD 43.08 billion by 2027.
- Demand for Precision oncology in defense is anticipated to witness moderate growth over the forecast period.
- North America is expected to be an active region over the forecast period. Numerous enterprises and several new players within and have been investing in advanced sensor manufacturing. The regional market is expected to exhibit a CAGR of 12.7% over the forecast period.

To identify the key trends in the industry, click on the link below: https://www.reportsanddata.com/report-detail/precision-oncology-market

For the purpose of this report, Reports and Data have segmented into the global Precision Oncology market on the basis of End-user, Technology Type, Application, and region:

End-user Outlook (Revenue, USD Billion; 2017-2027)

Pharmaceuticals Companies
Biotechnology Companies
Diagnostic Companies
Healthcare Data Companies

Technology Type Outlook (Revenue, USD Million; 2017-2027)

Big data Analytics
Bioinformatics
Gene Sequencing
Drug Discovery
Companies Diagnostics

Application Outlook (Revenue, USD Billion; 2017-2027)

Consumable
Instruments
Services

Regional Outlook (Revenue, USD Billion; 2017-2027)

North America
Europe
Asia Pacific
MEA
Latin America

Request for Customization: @ https://www.reportsanddata.com/request-customization-form/3353

Table of Content:

 Chapter 1. Market Synopsis
    1.1. Market Definition
    1.2. Research Scope & Premise
    1.3. Methodology
    1.4. Market Estimation Technique
Chapter 2. Executive Summary
    2.1. Summary Snapshot, 2019-2027
Chapter 3. Indicative Metrics
Chapter 4. Precision Oncology Market Segmentation & Impact Analysis
    4.1. Precision Oncology Market Material Segmentation Analysis
    4.2. Industrial Outlook
          4.2.1. Market indicators analysis
          4.2.2. Market drivers analysis
          4.2.3. Market restraints analysis
    4.3. Technological Insights
    4.4. Regulatory Framework
    4.5. ETOP Analysis
    4.6. Porter's Five Forces Analysis
    4.7. Competitive Metric Space Analysis
    4.8. Price trend Analysis
    4.9. Customer Mapping
    4.10. Covid-19 Impact Analysis
    4.11. Global Recession Influence
….
Chapter 9. Competitive Landscape
    9.1. Market Revenue Share By Manufacturers
    9.2. Manufacturing Cost Breakdown Analysis
    9.3. Mergers & Acquisitions
    9.4. Market positioning
    9.5. Strategy Benchmarking
    9.6. Vendor Landscape

Chapter 10. Company Profiles
    10.1. Eagle Genomics
          10.1.1. Company Overview
          10.1.2. Financial Performance
          10.1.3. Technology Insights
          10.1.4. Strategic Initiatives
    10.2. ASEBIO
          10.2.1. Company Overview
          10.2.2. Financial Performance
          10.2.3. Technology Insights
          10.2.4. Strategic Initiatives
    10.3. Menarini Silicon Biosystems
          10.3.1. Company Overview
          10.3.2. Financial Performance
          10.3.3. Technology Insights
          10.3.4. Strategic Initiatives
    10.4. NanoString Technologies, Inc.
          10.4.1. Company Overview
          10.4.2. Financial Performance
          10.4.3. Technology Insights
          10.4.4. Strategic Initiatives
    10.5. NeoGenomics
          10.5.1. Company Overview
          10.5.2. Financial Performance
          10.5.3. Technology Insights
          10.5.4. Strategic Initiatives
    10.6. Novartis AG
          10.6.1. Company Overview
          10.6.2. Financial Performance
          10.6.3. Technology Insights
          10.6.4. Strategic Initiatives

Continue…

Thank you for reading our report. For customization inquiry or further information, please connect with us and we will ensure you get the report that meets your requirements. 

Browse More Reports - 

Organic Poultry/Meat Farming Market Share

Dry Powder Inhaler Device Market Trends

Manganese Sulfate Market Size

Point of Care Molecular Diagnostics Market Share

Respiratory Disposables Market Trends

Heavy Metal Testing Market Growth

About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client's make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market.

Contact Us:

John W

Head of Business Development

Reports and Data | Web: www.reportsanddata.com

Direct Line: +1-212-710-1370

E-mail: sales@reportsanddata.com